Leflunomide (Arava)


Indications


Pharmacology


Administration

Dose-Adjustment


Adverse Effects

Gastrointestinal Adverse Effects

Pulmonary Adverse Effects

Acute Interstitial Pneumonia/Acute Lung Injury-ARDS (see Interstitial Lung Disease-Etiology, [[Interstitial Lung Disease-Etiology]] and Acute Lung Injury-ARDS, [[Acute Lung Injury-ARDS]])

Diffuse Alveolar Hemorrhage (DAH) (see Diffuse Alveolar Hemorrhage, [[Diffuse Alveolar Hemorrhage]])

Hypersensitivity Pneumonitis (HP) (see Hypersensitivity Pneumonitis, [[Hypersensitivity Pneumonitis]])

Induction of Rheumatoid Nodules (see Lung Nodule or Mass, [[Lung Nodule or Mass]])

Pulmonary Alveolar Proteinosis (PAP) (see Pulmonary Alveolar Proteinosis, [[Pulmonary Alveolar Proteinosis]])

Pulmonary Hypertension (see Pulmonary Hypertension, [[Pulmonary Hypertension]])

Pulmonary Infiltrates with Eosinophilia (see Drug-Induced Pulmonary Eosinophilia, [[Drug-Induced Pulmonary Eosinophilia]])

Other Adverse Effects


References